BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8571191)

  • 1. [Autologous bone marrow transplantation as early therapy for patients with aggressive non-Hodgkin's lymphoma].
    Havemann K; Kaiser U
    Strahlenther Onkol; 1996 Jan; 172(1):50-1. PubMed ID: 8571191
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Fielding AK; Pearce RM; Goldstone AH
    N Engl J Med; 1995 Sep; 333(11):729; author reply 730. PubMed ID: 7637758
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma.
    Verdonck LF
    J Clin Oncol; 1999 Sep; 17(9):3003. PubMed ID: 10627188
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Burke HB
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637756
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Nimer SD; Zelenetz A; Portlock C
    N Engl J Med; 1995 Sep; 333(11):728-9; author reply 730. PubMed ID: 7503899
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Mross K
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637757
    [No Abstract]   [Full Text] [Related]  

  • 7. [High-grade non-Hodgkin lymphoma: diagnosis and therapy].
    Trümper L; Pfreundschuh M
    Ther Umsch; 1996 Feb; 53(2):133-9. PubMed ID: 8629263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aggressive non-Hodgkin's lymphoma.
    Coiffier B
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):12-20. PubMed ID: 10561013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
    Nakamura S
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation in non-Hodgkin's lymphomas: prediction of mononuclear cell yield in bone marrow harvests.
    Rinaldi C; Savignano C; Silvestri F; Geromin A; Cerno M; Fanin R; Biffoni F; Baccarani M
    Haematologica; 1995; 80(5):443-7. PubMed ID: 8566888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunity.
    Fisher RI
    J Clin Oncol; 2002 Nov; 20(22):4411-2. PubMed ID: 12431961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-Hodgkin lymphoma].
    Ogawa M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1143-8. PubMed ID: 8751801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of aggressive non-Hodgkin's lymphomas].
    López A; Palacio C
    Med Clin (Barc); 1998 May; 110(16):614-8. PubMed ID: 9656199
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens.
    Sonneveld P
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):29-31. PubMed ID: 7863349
    [No Abstract]   [Full Text] [Related]  

  • 18. Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remaining.
    Fisher RI
    J Natl Cancer Inst; 2001 Jan; 93(1):4-5. PubMed ID: 11136829
    [No Abstract]   [Full Text] [Related]  

  • 19. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.